Novel conformation of histidyl-transfer RNA synthetase in the lung

The target tissue in Jo-1 autoantibody-associated myositis

Stuart M. Levine, Nina Raben, Dan Xie, Frederic B Askin, Rubin Tuder, Marissa Mullins, Antony Rosen, Livia A Casciola Rosen

Research output: Contribution to journalArticle

Abstract

Objective. We previously proposed that novel expression and/or conformation of autoantigens in the target tissue may play a role in generating phenotype-specific immune responses. The strong association of autoantibodies to histidyl-transfer RNA synthetase (HisRS, Jo-1) with interstitial lung disease in patients with myositis led us to study HisRS expression and conformation in the lung. Methods. Normal human tissue specimens were probed with a novel anti-HisRS antibody recognizing its granzyme B-cleavable conformation by immunoblotting and immunohistochemistry. The HisRS granzyme B site was mapped using site-directed mutagenesis, and its relationship to the antibody recognition domain was evaluated in tandem immunoprecipitation/granzyme B cleavage studies. Results. The HisRS α-helical coiled-coil N-terminal domain recognized by autoantibodies is bounded by a granzyme B cleavage site. In immunoprecipitation studies with patient sera, HisRS was found to exist in 2 conformations, defined by sensitivity to cleavage by granzyme B and modification by autoantibody binding. Despite similar global expression of HisRS in different tissue, expression of its granzyme B-cleavable form was enriched in the lung and localized to the alveolar epithelium. Conclusion. A proteolytically sensitive conformation of HisRS exists in the lung, the target tissue associated with this autoantibody response. We thus propose that autoimmunity to HisRS is initiated and propagated in the lung.

Original languageEnglish (US)
Pages (from-to)2729-2739
Number of pages11
JournalArthritis and Rheumatism
Volume56
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Amino Acyl-tRNA Synthetases
Granzymes
Myositis
Autoantibodies
Lung
Immunoprecipitation
Interstitial Lung Diseases
Autoantigens
Site-Directed Mutagenesis
Autoimmunity
Immunoblotting
Anti-Idiotypic Antibodies
Epithelium
Immunohistochemistry
Phenotype
Antibodies
Serum

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Novel conformation of histidyl-transfer RNA synthetase in the lung : The target tissue in Jo-1 autoantibody-associated myositis. / Levine, Stuart M.; Raben, Nina; Xie, Dan; Askin, Frederic B; Tuder, Rubin; Mullins, Marissa; Rosen, Antony; Casciola Rosen, Livia A.

In: Arthritis and Rheumatism, Vol. 56, No. 8, 08.2007, p. 2729-2739.

Research output: Contribution to journalArticle

@article{5d23c37b7ad544c0b9311777950d9fce,
title = "Novel conformation of histidyl-transfer RNA synthetase in the lung: The target tissue in Jo-1 autoantibody-associated myositis",
abstract = "Objective. We previously proposed that novel expression and/or conformation of autoantigens in the target tissue may play a role in generating phenotype-specific immune responses. The strong association of autoantibodies to histidyl-transfer RNA synthetase (HisRS, Jo-1) with interstitial lung disease in patients with myositis led us to study HisRS expression and conformation in the lung. Methods. Normal human tissue specimens were probed with a novel anti-HisRS antibody recognizing its granzyme B-cleavable conformation by immunoblotting and immunohistochemistry. The HisRS granzyme B site was mapped using site-directed mutagenesis, and its relationship to the antibody recognition domain was evaluated in tandem immunoprecipitation/granzyme B cleavage studies. Results. The HisRS α-helical coiled-coil N-terminal domain recognized by autoantibodies is bounded by a granzyme B cleavage site. In immunoprecipitation studies with patient sera, HisRS was found to exist in 2 conformations, defined by sensitivity to cleavage by granzyme B and modification by autoantibody binding. Despite similar global expression of HisRS in different tissue, expression of its granzyme B-cleavable form was enriched in the lung and localized to the alveolar epithelium. Conclusion. A proteolytically sensitive conformation of HisRS exists in the lung, the target tissue associated with this autoantibody response. We thus propose that autoimmunity to HisRS is initiated and propagated in the lung.",
author = "Levine, {Stuart M.} and Nina Raben and Dan Xie and Askin, {Frederic B} and Rubin Tuder and Marissa Mullins and Antony Rosen and {Casciola Rosen}, {Livia A}",
year = "2007",
month = "8",
doi = "10.1002/art.22790",
language = "English (US)",
volume = "56",
pages = "2729--2739",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Novel conformation of histidyl-transfer RNA synthetase in the lung

T2 - The target tissue in Jo-1 autoantibody-associated myositis

AU - Levine, Stuart M.

AU - Raben, Nina

AU - Xie, Dan

AU - Askin, Frederic B

AU - Tuder, Rubin

AU - Mullins, Marissa

AU - Rosen, Antony

AU - Casciola Rosen, Livia A

PY - 2007/8

Y1 - 2007/8

N2 - Objective. We previously proposed that novel expression and/or conformation of autoantigens in the target tissue may play a role in generating phenotype-specific immune responses. The strong association of autoantibodies to histidyl-transfer RNA synthetase (HisRS, Jo-1) with interstitial lung disease in patients with myositis led us to study HisRS expression and conformation in the lung. Methods. Normal human tissue specimens were probed with a novel anti-HisRS antibody recognizing its granzyme B-cleavable conformation by immunoblotting and immunohistochemistry. The HisRS granzyme B site was mapped using site-directed mutagenesis, and its relationship to the antibody recognition domain was evaluated in tandem immunoprecipitation/granzyme B cleavage studies. Results. The HisRS α-helical coiled-coil N-terminal domain recognized by autoantibodies is bounded by a granzyme B cleavage site. In immunoprecipitation studies with patient sera, HisRS was found to exist in 2 conformations, defined by sensitivity to cleavage by granzyme B and modification by autoantibody binding. Despite similar global expression of HisRS in different tissue, expression of its granzyme B-cleavable form was enriched in the lung and localized to the alveolar epithelium. Conclusion. A proteolytically sensitive conformation of HisRS exists in the lung, the target tissue associated with this autoantibody response. We thus propose that autoimmunity to HisRS is initiated and propagated in the lung.

AB - Objective. We previously proposed that novel expression and/or conformation of autoantigens in the target tissue may play a role in generating phenotype-specific immune responses. The strong association of autoantibodies to histidyl-transfer RNA synthetase (HisRS, Jo-1) with interstitial lung disease in patients with myositis led us to study HisRS expression and conformation in the lung. Methods. Normal human tissue specimens were probed with a novel anti-HisRS antibody recognizing its granzyme B-cleavable conformation by immunoblotting and immunohistochemistry. The HisRS granzyme B site was mapped using site-directed mutagenesis, and its relationship to the antibody recognition domain was evaluated in tandem immunoprecipitation/granzyme B cleavage studies. Results. The HisRS α-helical coiled-coil N-terminal domain recognized by autoantibodies is bounded by a granzyme B cleavage site. In immunoprecipitation studies with patient sera, HisRS was found to exist in 2 conformations, defined by sensitivity to cleavage by granzyme B and modification by autoantibody binding. Despite similar global expression of HisRS in different tissue, expression of its granzyme B-cleavable form was enriched in the lung and localized to the alveolar epithelium. Conclusion. A proteolytically sensitive conformation of HisRS exists in the lung, the target tissue associated with this autoantibody response. We thus propose that autoimmunity to HisRS is initiated and propagated in the lung.

UR - http://www.scopus.com/inward/record.url?scp=34547782671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547782671&partnerID=8YFLogxK

U2 - 10.1002/art.22790

DO - 10.1002/art.22790

M3 - Article

VL - 56

SP - 2729

EP - 2739

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 8

ER -